Online citations, reference lists, and bibliographies.

Biliary MR Imaging With Gd-EOB-DTPA And Its Clinical Applications.

Nam Kyung Lee, S. Kim, J. W. Lee, S. Lee, D. Kang, G. Kim, H. I. Seo
Published 2009 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
The hepatocyte-specific contrast agent gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) was developed to improve the detection and characterization of focal liver lesions at magnetic resonance (MR) imaging. Approximately 50% of the injected dose is taken up into the functional hepatocyte and is excreted via the biliary system. Because of this property, Gd-EOB-DTPA has the potential to be a biliary contrast agent. When combined with T2-weighted MR cholangiography, Gd-EOB-DTPA-enhanced MR imaging can allow morphologic and functional assessment of the biliary system. Gd-EOB-DTPA-enhanced MR cholangiography could be effective in evaluation of biliary anatomy, differentiation of biliary from extrabiliary lesions, diagnosis of cholecystitis, assessment of bile duct obstruction, detection of bile duct injury including leakage and stricture, evaluation of biliary-enteric anastomoses, postprocedure evaluation, differentiation of biloma from other pathologic conditions, and evaluation of sphincter of Oddi dysfunction. However, the clinical applications of this imaging technique have not yet been fully explored, and further investigations are needed to determine the utility of Gd-EOB-DTPA-enhanced MR cholangiography in a clinical setting.
This paper references
10.1007/s00464-007-9740-8
Iatrogenic biliary injury: 13,305 cholecystectomies experienced by a single surgical team over more than 13 years
O. Tantia (2007)
10.2214/AJR.184.5.01841563
Functional MR cholangiography: diagnosis of functional abnormalities of the gallbladder and biliary tree.
L. Fayad (2005)
10.1097/01.rli.0000184756.66360.d3
Comparison of Magnetic Properties of MRI Contrast Media Solutions at Different Magnetic Field Strengths
M. Rohrer (2005)
10.1148/radiology.195.3.7754011
Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging.
B. Hamm (1995)
10.1097/RCT.0b013e3180616b87
Visualization of the Biliary Tract Using Gadobenate Dimeglumine: Preliminary Findings
F. Ergen (2008)
10.2214/AJR.176.4.1760913
Ability of MR cholangiography to reveal stent position and luminal diameter in patients with biliary endoprostheses: in vitro measurements and in vivo results in 30 patients.
E. Merkle (2001)
10.1016/S0001-2998(03)00032-1
Acute cholecystitis, biliary obstruction, and biliary leakage.
H. Ziessman (2003)
10.1148/RADIOLOGY.218.1.R01JA2427
Contrast agents for MR imaging of the liver.
R. Semelka (2001)
10.1007/s00330-008-0929-6
Contrast-enhanced MR cholangiography with Gd-EOB-DTPA in patients with liver cirrhosis: visualization of the biliary ducts in comparison with patients with normal liver parenchyma
Frank T C Tschirch (2008)
10.1056/NEJM199907223410407
Magnetic resonance cholangiopancreatography.
M. Barish (1999)
10.1148/radiology.199.1.8633143
Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence.
P. Reimer (1996)
10.1007/s00330-007-0716-9
Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions
R. Hammerstingl (2007)
10.1148/radiology.199.1.8633178
MR cholangiopancreatography after unsuccessful or incomplete ERCP.
J. Soto (1996)
10.1016/S0016-5107(04)00297-4
Sphincter of Oddi dysfunction, part 2: Evidence-based review of the presentations, with "objective" pancreatic findings (types I and II) and of presumptive type III.
B. Petersen (2004)
10.2214/AJR.05.0584
Gadobenate dimeglumine-enhanced liver MRI as the sole preoperative imaging technique: a prospective study of living liver donors.
S. K. An (2006)
10.1016/S1076-6332(03)80565-2
Biliary imaging with Gd-EOB-DTPA: is a 20-minute delay sufficient?
R. Carlos (2002)
10.1148/RADIOL.2272020207
Acute cholecystitis at T2-weighted and manganese-enhanced T1-weighted MR cholangiography: preliminary study.
K. Kim (2003)
10.2214/AJR.177.2.1770389
Anatomic variants of the biliary tree: MR cholangiographic findings and clinical applications.
K. Mortelé (2001)
10.2214/AJR.184.5.01841556
MR cholangiography with manganese dipyridoxyl diphosphate in the evaluation of biliary-enteric anastomoses: preliminary experience.
N. Hottat (2005)
10.2214/AJR.179.4.1791053
Caroli's disease: radiologic spectrum with pathologic correlation.
A. D. Levy (2002)
10.1080/02841850701196922
Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects
N. Dahlström (2007)
10.2214/AJR.07.3485
Laparoscopic cholecystectomy: postoperative imaging.
P. Thurley (2008)
10.1148/RADIOL.2333031977
Defining intrahepatic biliary anatomy in living liver transplant donor candidates at mangafodipir trisodium-enhanced MR cholangiography versus conventional T2-weighted MR cholangiography.
V. Lee (2004)
10.1007/s00330-004-2236-1
Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications
P. Reimer (2004)
10.2214/ajr.183.6.01831559
Early biliary complications of laparoscopic cholecystectomy: evaluation on T2-weighted MR cholangiography in conjunction with mangafodipir trisodium-enhanced 3D T1-weighted MR cholangiography.
M. Park (2004)
10.1055/s-2007-1004213
What role can endoscopy play in the management of biliary complications after laparoscopic cholecystectomy?
F. Prat (1997)
10.3349/ymj.2007.48.6.1072
Value of Manganese-Enhanced T1- and T2-Weighted MR Cholangiography for Differentiating Cystic Parenchymal Lesions from Cystic Abnormalities which Communicate with Bile Ducts
Mi-Suk Park (2007)
MRI artifacts of metallic stents derived from imaging sequencing and the ferromagnetic nature of materials.
T. Nitatori (1999)
10.1055/s-2007-1004160
Clinical significance of magnetic resonance cholangiopancreatography (MRCP) compared to endoscopic retrograde cholangiopancreatography (ERCP).
R. Hintze (1997)
An analysis of the problem of biliary injury during laparoscopic cholecystectomy.
S. Strasberg (1995)
10.1148/RADIOGRAPHICS.20.3.G00MA16751
Gallbladder stones: imaging and intervention.
G. Bortoff (2000)
10.2214/AJR.179.1.1790087
Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid as an intrabiliary contrast agent: preliminary assessment.
R. Carlos (2002)
Positional biliary stasis: scintigraphic findings following biliary-enteric bypass surgery.
M. H. Lucas (1995)
Classification of iatrogenic bile duct injury.
W. Lau (2007)
10.1002/bjs.1800801232
Bile duct injury and bile leakage in laparoscopic cholecystectomy
S. Huang (1993)
10.1002/JMRI.21195
Double common bile duct: curved-planar reformatted computed tomography (CT) and gadobenate dimeglumine-enhanced MR cholangiography.
M. Park (2008)
10.1097/00004424-200111000-00008
Contrast-Enhanced Magnetic Resonance Cholangiography Versus Heavily T2-Weighted Magnetic Resonance Cholangiography
Nickolas Papanikolaou (2001)
10.1148/radiol.2441060920
Acute cholecystitis: MR findings and differentiation from chronic cholecystitis.
E. Altun (2007)
10.1007/s00261-004-0276-2
Bile duct leaks after laparoscopic cholecystectomy: value of contrast-enhanced MRCP
M. Aduna (2004)
10.1001/JAMA.289.1.80
DOES THIS PATIENT HAVE ACUTE CHOLECYSTITIS?
Robert L. Trowbridge (2003)
10.1002/JMRI.20114
Contrast-enhanced magnetic resonance cholangiography using mangafodipir compared with standard T2W MRC sequences: a pictorial essay.
D. Sheppard (2004)
10.1002/bjs.1800760715
Surgical significance of the bile duct of Luschka
T. McQuillan (1989)
10.1002/JMRI.10369
Functional magnetic resonance cholangiography (fMRC) of the gallbladder and biliary tree with contrast-enhanced magnetic resonance cholangiography.
L. Fayad (2003)
10.1067/MGE.2003.292
Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents.
M. Freeman (2003)
10.2214/AJR.169.3.9275901
MR cholangiography in the examination of patients with biliary-enteric anastomoses.
P. Pavone (1997)



This paper is referenced by
10.2214/AJR.12.8722
Effect of flip angle for optimization of image quality of gadoxetate disodium-enhanced biliary imaging at 1.5 T.
Sooah Kim (2013)
10.1007/978-1-4939-7677-5_30
Noninvasive Preclinical and Clinical Imaging of Liver Transporter Function Relevant to Drug-Induced Liver Injury
J. Gerry Kenna (2018)
10.2214/AJR.10.6076
An approach to pediatric liver MRI.
Courtney Mitchell (2011)
10.1007/s00247-011-2086-3
Functional hepatobiliary MR imaging in children
Anobel Tamrazi (2011)
10.1259/bjr/21209407
CT and MR cholangiography: advantages and pitfalls in perioperative evaluation of biliary tree.
T. Hyodo (2012)
10.1007/s00261-014-0235-5
Diffusion-weighted magnetic resonance imaging for non-neoplastic conditions in the hepatobiliary and pancreatic regions: pearls and potential pitfalls in imaging interpretation
Nam Kyung Lee (2014)
10.1002/jmri.25725
Additional values of high‐resolution gadoxetic acid‐enhanced MR cholangiography for evaluating the biliary anatomy of living liver donors: Comparison with T2‐weighted MR cholangiography and conventional gadoxetic acid‐enhanced MR cholangiography
Hyo-Jin Kang (2018)
Visualization of Regional Liver Function with Hepatobiliary Specific Contrast Agent Gd-EOB-DTPA
J. Samuelsson (2011)
10.1016/j.crad.2014.05.009
Feasibility of gadoxetate disodium-enhanced MR cholangiography in chronic cholestatic biliary disease.
J.-P. Kühn (2014)
10.5152/balkanmedj.2016.140872
The Impact of Gd-Eob-Dtpa-Enhanced MR Cholangiography in Biliary Diseases: Comparison with T2-Weighted MR Cholangiopancreatography.
Evrim Özmen (2016)
10.1007/s00261-013-0007-7
Biliary-enteric anastomoses: spectrum of findings on Gd-EOB-DTPA-enhanced MR cholangiography
Piero Boraschi (2013)
10.1590/0100-3984.2013.1867
Hepatobiliary contrast agents: differential diagnosis of focal hepatic lesions, pitfalls and other indications*
F. F. Francisco (2014)
10.2460/ajvr.78.7.828
Use of gadoxetic acid for computed tomographic cholangiography in healthy dogs.
Jennifer N. Chau (2017)
10.1016/j.clinre.2011.05.008
MR evaluation of biliary-enteric anastomotic stricture: does contrast-enhanced T1W MRC provide additional information?
Devasenathipathy Kandasamy (2011)
10.1186/s12885-015-1039-x
Cholangiocarcinoma: spectrum of appearances on Gd-EOB-DTPA-enhanced MR imaging and the effect of biliary function on signal intensity
Shi-Ting Feng (2015)
10.1007/s00261-011-9834-6
Early phase detection of bile leak after hepatobiliary surgery: value of Gd-EOB-DTPA-enhanced MR cholangiography
A. Castellanos (2011)
10.1007/978-3-540-88003-5_2
Gallbladder and Biliary System
Mariano M. Volpacchio (2012)
10.1016/j.ejrad.2016.04.008
Graft complications following orthotopic liver transplantation: Role of non-invasive cross-sectional imaging techniques.
Piero Boraschi (2016)
10.1097/RLI.0000000000000512
Clinical Feasibility of Gadoxetic Acid–Enhanced Isotropic High-Resolution 3-Dimensional Magnetic Resonance Cholangiography Using an Iterative Denoising Algorithm for Evaluation of the Biliary Anatomy of Living Liver Donors
Hyo-Jin Kang (2019)
10.1002/jmri.23978
Effects of gadoxetic acid on quantitative diffusion-weighted imaging of the liver.
Stefano Colagrande (2013)
10.1007/s00117-019-0503-z
Differenzialdiagnosen von Gallenwegerkrankungen
K. Lampichler (2019)
10.1007/s11604-011-0593-7
Usefulness of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance cholangiography for detecting mucin retention in bile ducts: a rare intraductal papillary mucinous neoplasm of the bile duct
Hodaka Oki (2011)
10.1016/j.acra.2014.02.005
Optimal timing and diagnostic adequacy of hepatocyte phase imaging with gadoxetate-enhanced liver MRI.
Mustafa R. Bashir (2014)
10.3748/wjg.v20.i32.11080
Postoperative biliary adverse events following orthotopic liver transplantation: assessment with magnetic resonance cholangiography.
Piero Boraschi (2014)
10.1590/0100-3984.2015.0213
Hepatocyte-specific contrast agent-enhanced magnetic resonance cholangiography: perioperative evaluation of the biliary tree
Luciana Zattar-Ramos (2017)
10.1016/j.jcma.2015.07.005
Dynamic‐contrast‐enhanced magnetic resonance imaging of cirrhotic liver parenchyma: A comparison between gadolinium–diethylenetriamine pentaacetic acid and gadolinium–ethoxybenzyl–diethylenetriamine pentaacetic acid
Chun-Yi Lin (2015)
10.1002/jmri.23816
Functional MR cholangiography of the cystic duct and sphincter of Oddi using gadoxetate disodium: is a 30-minute delay long enough?
M. Corwin (2013)
10.1016/j.clinimag.2013.11.001
Diagnosis of biliary stone disease: T1-weighted magnetic resonance cholangiography with Gd-EOB-DTPA versus T2-weighted magnetic resonance cholangiography.
In Young Choi (2014)
10.1016/j.lfs.2014.05.016
The hepatocyte phase of Gd-EOB-DTPA-enhanced MRI in the evaluation of hepatic fibrosis and early liver cirrhosis in a rat model: an experimental study.
Chunmei Ma (2014)
10.1111/hepr.12325
Recent advances in estimating hepatic functional reserve in patients with chronic liver damage.
Satoru Imura (2015)
10.1590/0100-3984.2013.1794
The role of gadoxetic acid as a paramagnetic contrast medium in the characterization and detection of focal liver lesions: a review
R. L. Bormann (2015)
10.1007/s00330-013-2880-4
Non-invasive detection of biliary leaks using Gd-EOB-DTPA-enhanced MR cholangiography: comparison with T2-weighted MR cholangiography
Mecit Kantarci (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar